Page 99 - 《中国药房》2023年23期

数，降低 FBG、D-二聚体水平，改善患者心功能、临床症 The Branch of Integrated Traditional Chinese and Western
状和中医证候疗效，同时不增加出血风险；其相比氯吡 Medicine Physicians of the Chinese Medical Association，
格雷或替格瑞洛方案在减少患者心绞痛发作次数方面 the Cardiovascular Disease Professional Committee of the
的疗效更为显著。 Chinese Association of Integrated Traditional Chinese and
参考文献 Western Medicine， the Critical Care Medicine Profes‐
sional Committee of the Chinese Association of Integrated
[ 1 ] WHO. World Health Statistics 2018[EB/OL]. （2018-06-
Traditional Chinese and Western Medicine，et al. Guide‐
06）[2023-03-18]. http：//apps.who.int/iris/bitstream/handle/
lines for the diagnosis and treatment of acute myocardial
10665/272596/9789241565585-eng.pdf?ua=1.
infarction by combining traditional Chinese and western
[ 2 ] BHATT D L，LOPES R D，HARRINGTON R A. Diagno‐
medicine[J]. Chin J Integr Tradit West Med，2018，38（3）：
sis and treatment of acute coronary syndromes：a review
272-284.
[J]. JAMA，2022，327（7）：662-675.
[ 9 ] MOSS A，DAGHEM M，TZOLOS E，et al. Coronary
[ 3 ] LUN R，DHALIWAL S，ZITIKYTE G，et al. Comparison
atherosclerotic plaque activity and future coronary events
of ticagrelor vs clopidogrel in addition to aspirin in pa‐
[J]. JAMA Cardiol，2023，8（8）：755-764.
tients with minor ischemic stroke and transient ischemic
[10] 郑筱萸. 中药新药临床研究指导原则：试行[M]. 北京：中
attack：a network meta-analysis[J]. JAMA Neurol，2022，
国医药科技出版社，2002：383.
79（2）：141-148.
ZHENG X Y. Guiding principles for clinical research of
[ 4 ] 申永艳，何贵新，肖婷，等. 不稳定型心绞痛中西医结合
new traditional Chinese medicine：trial implementation
诊疗新进展[J]. 大众科技，2019，21（11）：51-53，68.
[M]. Beijing：China Medical Science and Technology
SHEN Y Y，HE G X，XIAO T，et al. New progress in treat‐
Press，2002：383.
ment of unstable angina pectoris with integrated tradi‐
[11] FANG J Y，ZHANG X L. Effect of various doses of rosu-
tional Chinese and western medicine[J]. Pop Sci Technol，
vastatin in the treatment of elderly patients with unstable
2019，21（11）：51-53，68.
angina pectoris[J]. Am J Transl Res，2022，14（1）：
[ 5 ] WU M，YANG S J，LIU G J，et al. Treating unstable an‐
594-602.
gina with detoxifying and blood-activating formulae：a
[12] XUE Y，HU Z H，JING Y K，et al. Efficacy assessment of
randomized controlled trial[J]. J Ethnopharmacol，2021，
ticagrelor versus clopidogrel in Chinese patients with
281：114530.
acute coronary syndrome undergoing percutaneous coro‐
[ 6 ] 中华医学会心血管病学分会，中华心血管病杂志编辑委
nary intervention by data mining and machine-learning de‐
员会 . 非 ST 段抬高型急性冠状动脉综合征诊断和治疗
cision tree approaches[J]. J Clin Pharm Ther，2020，45
指南：2016[J]. 中华心血管病杂志，2017，45（5）：359-376.
（5）：1076-1086.
Chinese Society of Cardiology，Editorial Board of
[13] LI Y Z，TAO T Q，SONG D D，et al. Effects of Xuefu
Chinese Journal of Cardiovascular Diseases. Guidelines
zhuyu granules on patients with stable coronary heart di-
for diagnosis and treatment of non-ST-segment elevation
sease：a double-blind，randomized，and placebo-controlled
acute coronary syndrome：2016[J]. Chin J Cardiol，2017，
study[J]. Oxid Med Cell Longev，2021，2021：8877296.
45（5）：359-376.
[14] LIU H，LIANG J P，LI P B，et al. Core bioactive compo‐
[ 7 ] COLLET J P，THIELE H，BARBATO E，et al. 2020 ESC
nents promoting blood circulation in the traditional
guidelines for the management of acute coronary syn‐
Chinese medicine compound Xueshuantong capsule
dromes in patients presenting without persistent ST-
（CXC） based on the relevance analysis between chemical
segment elevation[J]. Rev Esp Cardiol，2021，74（6）：544.
HPLC fingerprint and in vivo biological effects[J]. PLoS
[ 8 ] 中国医师协会中西医结合医师分会，中国中西医结合学
One，2014，9（11）：e112675.
会心血管病专业委员会，中国中西医结合学会重症医学
（收稿日期：2023-05-29 修回日期：2023-11-02）
专业委员会，等. 急性心肌梗死中西医结合诊疗指南[J].
（编辑：胡晓霖）
中国中西医结合杂志，2018，38（3）：272-284.

中国药房 2023年第34卷第23期 China Pharmacy 2023 Vol. 34 No. 23 · 2905 ·